Home › Small Cell Lung Cancer › Texas › San Antonio
Small Cell Lung Cancer clinical trials in San Antonio, TX
11 studies for Small Cell Lung Cancer are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
RecruitingPhase 1/2
- START San Antonio (STSA), San Antonio
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
RecruitingPhase 1
- NEXT Oncology, San Antonio
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RecruitingPhase 1/2
- Avenzo Therapeutics Recruiting Site, San Antonio
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- Clinical Trial Site, San Antonio
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
RecruitingPhase 2/3
- Texas Oncology - San Antonio, San Antonio
- Texas Oncology - San Antonio, San Antonio
- Texas Oncology - San Antonio, San Antonio
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- New Experimental Therapeutics of San Antonio - NEXT Oncology, San Antonio
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- UT Health Mays Cancer Center, San Antonio
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
RecruitingPhase 1
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
RecruitingPhase 1/2
- Mays Cancer Center / University of Texas, San Antonio, San Antonio
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
- NEXT Oncology San Antonio, San Antonio
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- START San Antonio, San Antonio
Small Cell Lung Cancer trials in other cities
- Houston, TX26 studies
- New York City, NY23 studies
- Arlington, VA22 studies
- Boston, MA22 studies
- Los Angeles, CA20 studies
- Nashville, TN20 studies
- Orlando, FL14 studies
- Chicago, IL13 studies
- Cleveland, OH13 studies
- Dallas, TX13 studies
- St. Louis, MO13 studies
- Washington, DC13 studies
Other studies in San Antonio
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer45 studies
- Metastatic Cancer44 studies
- Colorectal Cancer43 studies
- Cancer (all types)41 studies
- Obesity39 studies
- Type 2 Diabetes37 studies
- Overweight34 studies
- Ovarian Cancer33 studies
- Pancreatic Cancer33 studies
- Lung Cancer27 studies
- Prostate Cancer27 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.